The Piperidine Bioisosteric Potential of 4-Azaspiro[2.3]hexane: Geometry, Physicochemical Properties, and Synthetic Accessibility

Introduction

Piperidine is a common saturated nitrogen-containing heterocycle in drug molecules. It can control the spatial positioning of substituents and can also participate in salt bridges, hydrogen bonding, and solvation through its protonatable nitrogen atom. When piperidine is replaced with another ring system, the spatial geometry, ionization behavior, and practical feasibility of subsequent synthesis all need to be considered.

Both 4-azaspiro[2.3]hexane and piperidine contain six ring-system heavy atoms, but they differ in atomic connectivity, conformational distribution, and the electronic environment of the nitrogen atom. In 2024, Galavskyy et al. systematically investigated the scalable synthesis, basicity, lipophilicity, single-crystal structures, and exit vectors of this scaffold, providing a relatively comprehensive chemical basis for its use as a candidate piperidine isosteric scaffold [2]. Because that study did not compare biological activity against specific drug targets, its conclusions primarily concern isosteric evaluation at the structural and physicochemical levels.

  

1. Evaluation Framework for Piperidine Bioisosteric Replacement

Bioisosteric replacement refers to the substitution of an existing structural unit with another structural element in order to retain key biological functions while modulating physicochemical properties, metabolic behavior, or safety characteristics [1]. Structural similarity can support a hypothesis for replacement, but the biological outcome in a specific compound still requires experimental validation.

The relationship between 4-azaspiro[2.3]hexane and piperidine can be evaluated at three levels.

Evaluation Level	Core Question	Main Research Methods
Geometric matching	Can the two scaffolds position substituents at similar three-dimensional locations?	Single-crystal X-ray diffraction, conformational analysis, exit vector plots
Ionization matching	How does ring-system replacement alter amine basicity, the degree of protonation, and lipophilicity?	Measurement of pKₐ, logP, and logD at specific pH values
Synthetic accessibility	Can sufficient quantities of derivatives with different attachment sites be obtained?	Route scale-up, functional-group transformations, matched molecular pair synthesis

These three levels respectively address whether the structures are similar, how their properties change, and whether the replacement can be systematically validated. Data from any one of these levels alone are insufficient to establish a functional bioisosteric relationship.

2. Geometric Matching: Connection-Point Distances and Substituent Directions

2.1 Ring-System Reconnection Alters the Conformational Distribution

Piperidine consists of a single six-membered ring and generally adopts a chair conformation, with ring flipping also possible. Substituents may adopt axial or equatorial orientations, and piperidine derivatives can therefore often access multiple interconverting conformations.

4-Azaspiro[2.3]hexane is formed by a cyclopropane and an azetidine ring sharing a common spiro carbon. These two small rings restrict the range of variation in bond angles and torsion angles, concentrating the substituents attached to the scaffold within a narrower range of spatial directions.

This conformational restriction does not in itself imply higher target activity. Its significance depends on the relationship between the constrained conformation and the biologically active conformation:

① When the constrained conformation is close to the conformation recognized by the target, scaffold replacement may reduce the extent of conformational reorganization required before binding;

② When the constrained conformation deviates from the binding conformation, the inherent flexibility of piperidine may be more favorable for adapting to the binding site.

Therefore, the key consideration when evaluating rigidification is not simply whether the number of accessible conformations is reduced, but whether the key substituents are positioned appropriately for target recognition.

2.2 Exit Vector Plots Describe the Three-Dimensional Relationships Between Substituents

An exit vector plot (EVP) is used to compare the relative orientations of two substituents in bifunctional scaffolds. Based on experimental crystal structures or reliable three-dimensional conformations, this method represents the spatial characteristics of a scaffold using several geometric parameters [3,4].

Parameter	Geometric Meaning
r	Distance between the two connection points
φ₁	Angle between the first exit vector and the connection axis
φ₂	Angle between the second exit vector and the connection axis
θ	Dihedral angle defined by the two exit vectors and the connection axis, reflecting the relative torsional relationship of the two exit vectors around the connection axis

An exit vector is the direction extending from a scaffold attachment atom toward an external substituent. Even when two ring systems have similar molecular volumes, substantial differences in r, φ₁, φ₂, or θ may cause the pharmacophores attached to them to occupy different spatial positions.

The EVP method was initially applied to the analysis of disubstituted cycloalkanes in the Cambridge Structural Database (CSD) and was subsequently extended to saturated heterocycles. Related studies have shown that different ring systems occupy significantly different regions of three-dimensional vector space, and that comparison based solely on ring size, heavy-atom count, or degree of saturation is insufficient to establish geometric isosterism [3,4].

2.3 Exit Vector Characteristics of 4-Azaspiro[2.3]hexane

Galavskyy et al. performed EVP analysis using single-crystal structures of representative derivatives. The results showed that the investigated 1,4-disubstituted 4-azaspiro[2.3]hexanes have exit vector characteristics similar to those of trans-1,4-disubstituted cyclohexanes and 1,4-disubstituted piperidines [2,6].

This result indicates that when an original molecule requires connection-point distances and substituent orientations similar to those of a 1,4-disubstituted piperidine, 4-azaspiro[2.3]hexane has a reasonable geometric basis for replacement.

EVP analysis primarily describes the static geometric relationships between connection points and does not directly account for the following factors:

① Protonation state of the nitrogen atom;

② Electrostatic potential at the scaffold surface;

③ Solvation and desolvation within the binding site;

④ Protein–ligand induced conformational changes;

⑤ Differences in local steric occupancy arising from the cyclopropane and azetidine rings.

Therefore, EVP is suitable for screening candidate replacement scaffolds, whereas biological activity and the actual binding mode still need to be established through matched molecular pairs and structural biology experiments.

3. Ionization Matching: Coupled Changes in pKₐ and Lipophilicity

3.1 pKₐ Determines the Protonation Ratio of an Amine

For a basic amine B, its basicity is commonly expressed using the acid dissociation constant of its conjugate acid BH⁺.

Acid–base equilibrium:

BH⁺ ⇌ B + H⁺

Henderson–Hasselbalch equation:

pH = pKₐ(BH⁺) + log₁₀([B]/[BH⁺])

Thus:

[B]/[BH⁺] = 10^(pH − pKₐ)

At the same pH, a decrease in pKₐ by one unit increases the ratio of neutral amine B to protonated amine BH⁺ by approximately tenfold. Changes in pKₐ affect the forms in which a molecule exists in aqueous media, cell membranes, and protein binding sites, and can consequently influence solubility, passive permeability, and ionic interactions [5].

It should be noted that a change in the ratio of the neutral and protonated forms does not necessarily mean that the neutral form becomes predominant. If the pKₐ values of both compounds remain substantially higher than the environmental pH, both compounds may still exist predominantly as BH⁺.

3.2 Why Ring-System Reconnection Alters Amine Basicity

The pKₐ of an amine depends on the free-energy difference between the neutral amine B and the protonated ammonium ion BH⁺. Reconnecting piperidine into a cyclopropane–azetidine spirocyclic system simultaneously alters the following factors:

1. σ-Bond Inductive Effects

Changes in the connectivity of the carbon framework surrounding the nitrogen atom alter the electronic distribution around the nitrogen lone pair and its ability to accept a proton.

2. Bond-Angle and Conformational Constraints

The four-membered and three-membered rings restrict bond angles and torsion angles around the C–N bonds, placing the neutral amine and protonated ammonium ion in geometric environments different from those in piperidine.

3. Solvation of the Charged Form

Changes in scaffold shape and charge exposure also alter the interactions between BH⁺ and water molecules. The aqueous pKₐ therefore reflects the combined effects of electronic factors, molecular conformation, and solvation.

Accordingly, the change in the basicity of 4-azaspiro[2.3]hexane is not determined by a single “ring-strain” factor, but is an experimentally observed result arising from multiple structural effects.

3.3 Changes in pKₐ and logP in the Original Study

In the model compounds used in the original study, replacement of piperidine with 4-azaspiro[2.3]hexane resulted in:

① A decrease in pKₐ of approximately 0.9 units;

② An increase in logP of approximately 0.5 units [2].

When pKₐ decreases by 0.9 units, at the same pH:

the [B]/[BH⁺] ratio increases by approximately 10^0.9, or about 7.9-fold.

These values were obtained from comparisons between specific model compounds. Substituent electronic effects, attachment positions, and the overall molecular structure may all alter the actual magnitude of these differences, and the values should therefore not be regarded as fixed changes applicable to all 4-azaspiro[2.3]hexane derivatives.

logP is the common logarithm of the partition coefficient of a neutral molecule between n-octanol and water and is used to describe the lipophilicity of the neutral form. For ionizable amines, the distribution coefficient logD can also be measured at a specific pH, such as logD₇.₄ under physiologically relevant conditions. logD reflects the combined partitioning behavior of the neutral and ionized forms at that pH.

A decrease in pKₐ and an increase in logP may produce interrelated effects.

Property Characteristics of the Original Compound	Possible Changes After Replacement	Recommended Data to Measure in Parallel
Relatively strong amine basicity and a low proportion of the neutral form	The proportion of the neutral form may increase	pKₐ, logD₇.₄, membrane permeability
The piperidine nitrogen participates in a key salt bridge	A lower degree of protonation may affect binding	Target activity, binding structure, pH-dependent activity
Insufficient lipophilicity of the neutral form	Increased logP may enhance hydrophobic interactions	Activity, nonspecific binding, metabolic stability
Aqueous solubility is already low	Lower basicity combined with increased logP may further reduce solubility	Thermodynamic solubility, solubility at different pH values

It is therefore clear that a decrease in pKₐ or an increase in logP does not in itself indicate an improvement in drug properties. The outcome must be evaluated in the context of the limitations of the original compound, its target-binding mode, and the complete physicochemical property profile.

4. Synthetic Accessibility: From a Single Structure to a Comparable Compound Series

4.1 Synthetic Role of a Common Alkene Intermediate

In the original study, tert-butoxycarbonyl (Boc)-protected 2-azetidinone was used as the starting material. Dimethyltitanocene, namely the Petasis reagent Cp₂Ti(CH₃)₂, was employed for Tebbe-type carbonyl methylenation to afford an N-Boc-protected methyleneazetidine [2].

Core synthetic route:

N-Boc-2-azetidinone

→ Petasis reagent-mediated carbonyl methylenation

→ N-Boc-methyleneazetidine

→ Cyclopropanation

→ 4-Azaspiro[2.3]hexane derivatives

The key feature of this route is the conversion of the carbonyl group into an exocyclic double bond. This double bond can undergo different types of cyclopropanation reactions to provide, from the corresponding methyleneazetidine intermediates:

① Unsubstituted 4-azaspiro[2.3]hexane;

② gem-Difluoro-substituted derivatives;

③ Derivatives bearing carboxylate ester substituents;

④ Corresponding isotopically labeled derivatives. (For isotopically labeled derivatives, the corresponding deuterated alkene precursor must first be prepared at the carbonyl methylenation stage using the deuterated Petasis reagent Cp₂Ti(CD₃)₂, followed by cyclopropanation.)

The carboxylate ester-containing products can also be converted into carboxylic acids and subsequently subjected to Curtius rearrangement and deprotection to afford mono-Boc-protected diamine building blocks. Thus, the cyclopropanation step not only constructs the spirocyclic ring system but also introduces functional groups required for subsequent attachment of pharmacophores [2].

4.2 Significance of Scale-Up for Bioisosteric Studies

Representative building blocks in this study were prepared on a multigram scale, with the largest single-batch scale reaching 52 g [2]. This demonstrates that the relevant compounds can provide sufficient material for subsequent derivatization, parallel synthesis, and multiple rounds of property testing.

Scaffold comparisons in medicinal chemistry commonly employ matched molecular pairs, in which two compounds retain, as far as possible, the same substituents and attachment patterns while differing only in the ring system being evaluated. Robust scalable routes and functional groups amenable to further transformation facilitate the construction of multiple matched molecular pairs and help distinguish the effects of:

① Differences intrinsic to the piperidine and spirocyclic scaffolds;

② Substituent electronic effects;

③ Cis/trans isomerism or enantiomerism;

④ Geometric differences arising from different attachment positions.

If a study includes only a single spirocyclic compound, changes in activity or properties may simultaneously reflect multiple structural variables. Data obtained from a series of structurally related compounds are more useful for establishing interpretable structure–activity relationships and structure–property relationships.

5. Validation Methods in Drug Discovery Programs

5.1 Define the Function of the Original Piperidine

Before performing a ring-system replacement, it is necessary to determine the principal role played by piperidine in the original compound.

Question to Be Addressed	Evidence That Can Be Used
Is piperidine primarily used to control the spatial relationship between two pharmacophores?	Co-crystal structures, conformational analysis, known structure–activity relationships
Does the piperidine nitrogen form a key salt bridge or hydrogen bond?	Protein–ligand structures, N-substitution experiments, pH-dependent activity
What are the main property limitations of the original series?	pKₐ, logD, solubility, permeability, and metabolic data

When piperidine primarily serves as a 1,4-linking unit, 4-azaspiro[2.3]hexane has a relatively clear geometric basis for comparison. If the piperidine nitrogen directly participates in a key ionic interaction, particular attention should be paid to changes in pKₐ and the degree of protonation after replacement.

5.2 Construct Matched Molecular Pairs

A basic comparison can include:

1. The original piperidine compound;

2. A 4-azaspiro[2.3]hexane compound with the same substituents and attachment positions on both sides.

If further investigation of electronic effects is required, gem-difluoro derivatives can be introduced in a second round. Examining scaffold changes and substituent changes in separate stages helps reduce the number of variables affecting the experimental results.

5.3 Measure Activity and Key Properties in Parallel

Data Category	Recommended Measurements	Main Purpose
Target interaction	Biochemical activity, cellular activity, selectivity	Determine whether key binding interactions are retained
Ionization	Experimentally measured pKₐ	Determine changes in protonation state
Partitioning properties	logP, logD₇.₄	Distinguish neutral-state lipophilicity from partitioning behavior at physiological pH
Aqueous properties	Solubility at different pH values	Determine how changes in ionization affect solubility
Membrane transport behavior	Artificial-membrane or cell-monolayer permeability	Determine whether changes in the neutral fraction affect membrane transport
Structural validation	Co-crystal structures, NMR conformational analysis, or validated computational models	Determine the binding pose and changes in exit vectors

If the spirocyclic analogue retains target activity while shifting pKₐ, logD, solubility, or permeability in directions that meet the needs of the project, an experimentally supported functional bioisosteric relationship can be established within that compound series.

If activity decreases, exit vectors, nitrogen protonation state, and local steric occupancy can be examined separately to avoid attributing the result simply to increased rigidity.

6. Conclusion

Current studies provide three lines of evidence supporting 4-azaspiro[2.3]hexane as a candidate piperidine isosteric scaffold.

1. Geometry

The investigated 1,4-disubstituted structures exhibit exit vector characteristics similar to those of 1,4-disubstituted piperidines and can therefore be used to preserve specific connection-point distances and substituent orientations.

2. Ionization

In model compounds, this replacement decreases pKₐ by approximately 0.9 units and increases logP by approximately 0.5 units, demonstrating that ring-system reconnection simultaneously alters the protonation behavior of the nitrogen atom and the lipophilicity of the neutral molecule.

3. Synthesis

Starting from N-Boc-2-azetidinone, carbonyl methylenation followed by cyclopropanation can provide a variety of functionalized derivatives. Representative building blocks have been prepared on scales of up to 52 g, providing a material basis for matched molecular pair synthesis and systematic property evaluation.

These findings support the inclusion of 4-azaspiro[2.3]hexane in studies of piperidine replacement. Whether it forms an effective bioisosteric relationship in a specific project depends on whether three conditions can be simultaneously satisfied: preservation of the spatial relationships of key substituents, changes in ionization and lipophilicity that are consistent with the optimization objectives, and matched molecular pairs that demonstrate reproducible retention of key biological activity together with property changes that meet the needs of the project.

7. Representative Chemicals Related to 4-Azaspiro[2.3]hexane Bioisostere Research: Scaffold Building Blocks, Ring-System Construction, and Functionalization Reagents

Table 1. Core Scaffolds, Comparator Scaffolds, and Spirocyclic Building Blocks

Category	CAS No.	Aladdin Catalog No.	Name	Specification or Purity	Product Features and Applications
Piperidine parent scaffold control	110-89-4	P1506346	Piperidine (Precursor Chemical)	Biotechnology Grade, ≥99.5%	Serves as the parent piperidine scaffold for matched molecular pair design with azaspirocyclic analogues and for comparative studies of basicity, lipophilicity, conformation, and biological activity.
4-Azaspiro[2.3]hexane core building block	125441-13-6	A1250503	4-Azaspiro(2.3)hexane	≥98%	Core 4-azaspiro[2.3]hexane scaffold that can be used for piperidine scaffold replacement, conformational restriction studies, and the design and derivatization of spirocyclic amine-containing drug molecules.
4-Azaspiro[2.3]hexane salt-form building block	1980048-81-4	A677730	4-azaspiro[2.3]hexane;oxalic acid	≥97%	Oxalate salt form of 4-azaspiro[2.3]hexane, facilitating stable storage and weighing. It can be used as a spirocyclic amine intermediate for subsequent bond-forming reactions, salt-form conversion, and medicinal chemistry research.
5-Azaspiro[2.3]hexane comparator building block	1536169-63-7	A629607	5-azaspiro[2.3]hexane hydrochloride	≥97%	A structural isomeric scaffold of 4-azaspiro[2.3]hexane that can be used to compare the effects of nitrogen-atom position on exit vectors, basicity, conformation, and biological activity.
5-Azaspiro[2.3]hexane comparator building block	1638767-88-0	A174827	5-Azaspiro[2.3]hexane hemioxalate	≥97%	A salt-form building block of 5-azaspiro[2.3]hexane that can be used for comparison of spirocyclic positional isomers, amine derivatization, and structure–activity relationship studies of different azaspirocyclic scaffolds.
Azaspiro[3.3]heptane comparator building block	1259489-92-3	T173071	tert-Butyl 2-azaspiro[3.3]heptane-2-carboxylate	≥97%	A protected azaspiro[3.3]heptane building block that can be used for comparison with piperidine and azaspiro[2.3]hexane to investigate the effects of ring size, rigidity, and three-dimensional connectivity on molecular properties.
Azaspiro[3.3]heptane comparator building block	1420271-08-4	A729841	2-Azaspiro[3.3]heptane hydrochloride	≥97%	Can be used directly in the preparation of azaspiro[3.3]heptane amine derivatives and is suitable for piperidine replacement studies, comparisons of different spirocyclic ring sizes, and medicinal chemistry structure–activity relationship research.

Table 2. Reagents for Scaffold Construction and Cyclopropane Functionalization

Category	CAS No.	Aladdin Catalog No.	Name	Specification or Purity	Product Features and Applications
Starting material for Petasis reagent preparation	1271-19-8	T106759	Titanocene dichloride	≥97%	A key titanium source for the preparation of dimethyltitanocene. It can be used to construct carbonyl methylenation reagent systems for the conversion of 2-azetidinone into an exocyclic methylene intermediate.
Starting material for Petasis reagent preparation	676-58-4	M119433	Methylmagnesium chloride solution	3.0 M in THF	Can react with titanocene dichloride to prepare dimethyltitanocene and can be used in carbonyl methylenation studies and in the synthesis of key alkene precursors for 4-azaspiro[2.3]hexane.
Cyclopropanation reagent	75-11-6	D104755	Diiodomethane	≥98% (GC), stabilized with copper	A methylene source for Simmons–Smith-type cyclopropanation. It can be used together with organozinc reagents to convert an exocyclic double bond into a cyclopropane, thereby constructing the 4-azaspiro[2.3]hexane scaffold.
Cyclopropanation reagent	557-20-0	D684313	Diethylzinc solution	2 M in toluene	Can form an active cyclopropanation species with diiodomethane and can be used for the cyclopropanation of methyleneazetidine and preparation of the core 4-azaspiro[2.3]hexane scaffold.
gem-Difluorocyclopropanation reagent	81290-20-2	T299032	(Trifluoromethyl)trimethylsilane (TFMTMS)	≥98%	Can be used to construct gem-difluorocyclopropane structures. In 4-azaspiro[2.3]hexane research, it can be used to introduce difluoro substitution and investigate the modulation of amine basicity and lipophilicity by fluorination.
gem-Difluorocyclopropanation additive	7681-82-5	S433814	Sodium iodide	Anhydrous Grade, Reagent Grade, High Purity, ≥99%	Can participate in the activation of fluorinated cyclopropanation reaction systems and can be used in the conversion of exocyclic alkenes into gem-difluorocyclopropane derivatives and in research on fluorinated spirocyclic building blocks.
Carboxylate ester-substituted cyclopropanation reagent	623-73-4	E433136	Ethyl diazoacetate	15% in toluene	Can serve as a carbene precursor in metal-catalyzed cyclopropanation, simultaneously constructing a three-membered ring and introducing a carboxylate ester functional group onto an exocyclic double bond, thereby providing a functional handle for the subsequent preparation of carboxylic acid, amine, and other derivatives.
Cyclopropanation catalyst	13395-16-9	C109323	Copper(II) acetylacetonate	≥97%	Can catalyze the cyclopropanation of alkenes with ethyl diazoacetate and can be used to prepare carboxylate ester-substituted 4-azaspiro[2.3]hexane intermediates for subsequent functional-group transformations.

Table 3. Reagents for Deprotection and Subsequent Functional-Group Transformations

Category	CAS No.	Aladdin Catalog No.	Name	Specification or Purity	Product Features and Applications
Acidic deprotection reagent	76-05-1	T433655	Trifluoroacetic acid (TFA)	Anhydrous Grade, ≥99%	Commonly used for the acidic deprotection of tert-butoxycarbonyl-protected amines, typically affording the corresponding amine trifluoroacetate salts. Free amines can be obtained after appropriate basification and used for subsequent coupling, salt formation, or salt-form conversion.
Curtius rearrangement reagent	26386-88-9	D106412	Diphenyl phosphoryl azide (DPPA)	≥97%	Can be used to convert carboxylic acids into amines through acyl azide formation and Curtius rearrangement and is suitable for the synthesis of diamine building blocks from functionalized 4-azaspiro[2.3]hexane carboxylic acids.

Note: The products listed above are representative Aladdin products related to scientific research. Specific applications should be determined according to product specifications, batch-specific COAs, and the intended reaction or evaluation system. Additional information on product specifications, grades, and COAs can be retrieved from the Aladdin website using the “product name/CAS/catalog number.”

References

[1] Patani G A, LaVoie E J. Bioisosterism: A Rational Approach in Drug Design[J]. Chemical Reviews, 1996, 96(8): 3147–3176. DOI: 10.1021/cr950066q.

[2] Galavskyy S, Chernykh A, Liashuk O, Lesyk D, Shishkina S V, Kliukovskyi D, Volochnyuk D M, Ryabukhin S V, Grygorenko O O. 4-Azaspiro[2.3]hexane, an Overlooked Piperidine Isostere: Multigram Synthesis and Physicochemical and Structural Evaluation[J]. The Journal of Organic Chemistry, 2024, 89(24): 18477–18486. DOI: 10.1021/acs.joc.4c02390.

[3] Grygorenko O O, Babenko P, Volochnyuk D M, Raievskyi O, Komarov I V. Following Ramachandran: Exit Vector Plots (EVP) as a Tool to Navigate Chemical Space Covered by 3D Bifunctional Scaffolds. The Case of Cycloalkanes[J]. RSC Advances, 2016, 6(21): 17595–17605. DOI: 10.1039/C5RA19958A.

[4] Grygorenko O O, Demenko D, Volochnyuk D M, Komarov I V. Following Ramachandran 2: Exit Vector Plot (EVP) Analysis of Disubstituted Saturated Rings[J]. New Journal of Chemistry, 2018, 42(11): 8355–8365. DOI: 10.1039/C7NJ05015A.

[5] Charifson P S, Walters W P. Acidic and Basic Drugs in Medicinal Chemistry: A Perspective[J]. Journal of Medicinal Chemistry, 2014, 57(23): 9701–9717. DOI: 10.1021/jm501000a.

[6] Natho P, Colella M, Luisi R. Strained Spiro Heterocycles as Potential Bioisosteres: An Update on the Synthesis of Heteroatom-Containing Spiro[2.3]hexanes and Spiro[3.3]heptanes[J]. Chemical Communications, 2025, 61(36): 6579–6594. DOI: 10.1039/D5CC00656B.

For more related articles, see below:

One Atom Can Change a Drug’s Fate: Atom-Level Knobs and a Functional-Group Toolbox for Medicinal Chemistry (Methyl / Halogen Bonding / 3D Building Blocks / Late-Stage Fluorination + Product-Selection Tables)

The Role of 7-Membered Nitrogen Heterocycles in Drug Discovery: Microstate Management, Conformational Bias, and Developability Trade-offs (with Research Selection Navigator and Product Tables 1–3)

Pyridinones as “Property Knobs” in Drug Design: From Tautomers and H-Bonding Fingerprints to Product Selection (Tables A–C)

Piperazine Selection Guide: Using a “Six-Membered Diaza Ring” to Make Salt Forms and Linking Strategies More Controllable (Appendix Tables 1–4 Product Navigator)

Why Do We So Often Add a “Morpholine Ring” to Molecules? — Definitions, Structural Features, and a Selection Guide to Morpholine/Thiomorpholine (with Tables 1–4)

Piperidine and Its Derivatives: Controllable Design of Charge, Conformation, and Connecting Exit with Product Navigation (Tables 1–5)

Indazole (Indazole) Scaffold Explained: How Adjacent Nitrogens, Tautomerism, and Substitution Sites Make H-Bonding and Acid–Base Behavior Tunable

From Indole to Azaindoles: A One-Nitrogen “Control Knob” for Tunable Properties and Scaffold Selection

Indole Product Navigation: How N-Position State, the C3 Connection Handle, and Core Scaffold Variants Map to Synthetic Interfaces and Research Uses (Tables A–E)

Applications of imidazole and its derivatives

From Piperidine to Homopiperidine: How a Seven-Membered Nitrogen Ring Redirects Substituent Vectors and Shifts Salt Formation/Solubility Behavior (Tables 1–3)

From Piperidine to Pyridine: The “Most Common N-Heterocycle” Shift in FDA Small-Molecule New Drugs (2013–2023) and a Selection Guide (Tables 1–4)

Substituted Azetidines in pharmaceutical chemistry, organic synthesis, and biochemistry

Medicinal Chemistry Value of Heteroatom-Containing Small-Ring Spirocycles: Classical Heterocycle Replacement and Three-Dimensional Exit Vector Remodeling

Rationale for Applying Spirocyclic Building Blocks in Drug Molecule Optimization: Three-Dimensionalization, Conformational Control, and Property Trade-offs

Innovations in the design of stereospecific drug molecular structures: Spirocyclic Scaffolds

Oxetane: Property-Window Optimization and a Building-Block Selection Guide (Tables 1–4)

Cyclic isomers--Azabicyclic molecular building blocks to aid drug design